Geron reported $-10.79M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Amgen USD 3.96B 464M Dec/2025
Bio Techne USD 54.46M 6.8M Dec/2025
Cassava Sciences USD -11.86M 2.23M Sep/2025
Cytokinetics USD -178.37M 11.61M Dec/2025
Esperion Therapeutics USD 85.23M 95.19M Dec/2025
Exelixis USD 235.91M 20.45M Dec/2025
Genmab DKK 360M 172M Jun/2025
Geron USD -10.79M 3.1M Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
Incyte USD 383.88M 47.43M Dec/2025
MacroGenics USD 18.64M 55.4M Sep/2025
Novartis USD 4.5B 363M Sep/2025
Novavax USD 20.94M 100.32M Dec/2025